Methadone concentrations in plasma and their relationship to drug dosage
- PMID: 1993325
Methadone concentrations in plasma and their relationship to drug dosage
Abstract
We have developed a sensitive HPLC method for measuring methadone in plasma and have used it to establish that there is a linear relationship between plasma concentration and methadone dose over the range of 3-100 mg of methadone per day in a group of 31 addicts. We found a good correlation between dose and plasma concentration (r = 0.89), with the plasma methadone concentration increasing by 0.263 mg/L for every milligram of methadone consumed per kilogram of body weight. Five patients had unexpected high or low concentrations; this finding is discussed.
Comment in
-
Methadone concentrations in plasma and their relationship to drug dosage.Clin Chem. 1992 Mar;38(3):438-9. Clin Chem. 1992. PMID: 1547571 No abstract available.
Similar articles
-
Can Saliva and Plasma Methadone Concentrations Be Used for Enantioselective Pharmacokinetic and Pharmacodynamic Studies in Patients With Advanced Cancer?Clin Ther. 2017 Sep;39(9):1840-1848. doi: 10.1016/j.clinthera.2017.07.044. Epub 2017 Aug 18. Clin Ther. 2017. PMID: 28827023 Clinical Trial.
-
Developing of LC/MS method with microwave assisted extraction for determination of methadone and it major metabolite (EDDP) in the blood of patients of methadone maintenance treatment.Przegl Lek. 2009;66(10):850-2. Przegl Lek. 2009. PMID: 20301952
-
Measuring compliance in methadone maintenance patients: use of a pharmacologic indicator to "estimate" methadone plasma levels.Clin Pharmacol Ther. 1991 Aug;50(2):199-207. doi: 10.1038/clpt.1991.125. Clin Pharmacol Ther. 1991. PMID: 1868680 Clinical Trial.
-
Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence.Clin Pharmacokinet. 2002;41(14):1153-93. doi: 10.2165/00003088-200241140-00003. Clin Pharmacokinet. 2002. PMID: 12405865 Review.
-
High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.Clin Pharmacokinet. 1986 Mar-Apr;11(2):87-106. doi: 10.2165/00003088-198611020-00001. Clin Pharmacokinet. 1986. PMID: 3514045 Review.
Cited by
-
Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patients.Br J Clin Pharmacol. 2000 Nov;50(5):427-40. doi: 10.1046/j.1365-2125.2000.00272.x. Br J Clin Pharmacol. 2000. PMID: 11069437 Free PMC article.
-
Sex specificity in methadone analgesia in the rat: a population pharmacokinetic and pharmacodynamic approach.Pharm Res. 2002 Jun;19(6):858-67. doi: 10.1023/a:1016117218760. Pharm Res. 2002. PMID: 12134958
-
Rapid determination of methadone in plasma, cerebrospinal fluid, and urine by gas chromatography and its application to routine drug monitoring.Pharm Res. 1993 Mar;10(3):441-4. doi: 10.1023/a:1018904825958. Pharm Res. 1993. PMID: 8464820
-
Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use.Am J Public Health. 1995 Jan;85(1):83-8. doi: 10.2105/ajph.85.1.83. Am J Public Health. 1995. PMID: 7832267 Free PMC article.
-
Methadone maintenance treatment. Treatment should be tailored for each patient.BMJ. 1995 Feb 18;310(6977):463-4. doi: 10.1136/bmj.310.6977.463b. BMJ. 1995. PMID: 7755729 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources